We are live on ! Find out more
BC

Bridgefront Capital Portfolio holdings

AUM $402M
1-Year Est. Return 18.17%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+18.17%
3 Year Est. Return
+38.15%
5 Year Est. Return
+29.06%
10 Year Est. Return
AUM
$398M
AUM Growth
+$57.9M
Cap. Flow
+$62.7M
Cap. Flow %
15.76%
Top 10 Hldgs %
9.72%
Holding
829
New
268
Increased
140
Reduced
84
Closed
337

Top Buys

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$5.85M
2
MSFT icon
Microsoft
MSFT
+$3.81M
3
MCD icon
McDonald's
MCD
+$3.5M
4
VEEV icon
Veeva Systems
VEEV
+$3.39M
5
GIS icon
General Mills
GIS
+$3.2M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$4.81M
2
HON icon
Honeywell
HON
+$3.09M
3
GWRE icon
Guidewire Software
GWRE
+$2.64M
4
V icon
Visa
V
+$2.58M
5
MO icon
Altria Group
MO
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Consumer Discretionary 13.84%
3 Healthcare 13.56%
4 Industrials 13%
5 Financials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRRM icon
376
Verra Mobility
VRRM
$615M
$295K 0.07%
+13,147
New +$300K
SNAP icon
377
Snap
SNAP
$7.32B
$294K 0.07%
+36,423
New +$288K
DTE icon
378
DTE Energy
DTE
$31.1B
$293K 0.07%
+2,269
New +$308K
BWXT icon
379
BWX Technologies
BWXT
$16B
$286K 0.07%
+1,652
New +$310K
MUR icon
380
Murphy Oil
MUR
$5.58B
$285K 0.07%
+9,119
New +$274K
RHI icon
381
Robert Half
RHI
$3.61B
$285K 0.07%
+10,483
New +$299K
APLS
382
DELISTED
Apellis Pharmaceuticals
APLS
$285K 0.07%
+11,326
New +$266K
QLYS icon
383
Qualys
QLYS
$4.84B
$283K 0.07%
+2,133
New +$293K
IAG icon
384
IAMGOLD
IAG
$8.47B
$283K 0.07%
+17,175
New +$242K
PG icon
385
Procter & Gamble
PG
$343B
$282K 0.07%
1,969
-12,954
-87% -$1.91M
PHAT icon
386
Phathom Pharmaceuticals
PHAT
$912M
$282K 0.07%
+16,981
New +$243K
FIGS icon
387
FIGS
FIGS
$1.59B
$280K 0.07%
+24,665
New +$231K
RS icon
388
Reliance Steel & Aluminium
RS
$20.8B
$275K 0.07%
+953
New +$268K
XP icon
389
XP
XP
$8.62B
$274K 0.07%
16,725
+4,199
+34% +$73.9K
LTM
390
LATAM Airlines Group S.A.
LTM
$14.4B
$273K 0.07%
+5,059
New +$240K
GM icon
391
General Motors
GM
$74.7B
$273K 0.07%
3,360
-12,381
-79% -$873K
COLD icon
392
Americold
COLD
$4.09B
$273K 0.07%
21,232
-32,924
-61% -$404K
AMD icon
393
Advanced Micro Devices
AMD
$851B
$272K 0.07%
+1,272
New +$286K
EVER icon
394
EverQuote
EVER
$886M
$271K 0.07%
+10,037
New +$243K
BMY icon
395
Bristol-Myers Squibb
BMY
$127B
$270K 0.07%
5,011
-28,393
-85% -$1.37M
TTAN
396
ServiceTitan Inc
TTAN
$6.72B
$268K 0.07%
+2,513
New +$245K
AMX icon
397
America Movil
AMX
$78.1B
$267K 0.07%
+12,912
New +$284K
CDNA icon
398
CareDx
CDNA
$1.92B
$266K 0.07%
+14,142
New +$237K
CDRE icon
399
Cadre Holdings
CDRE
$1.32B
$263K 0.07%
+6,436
New +$268K
XMTR icon
400
Xometry
XMTR
$4.77B
$261K 0.07%
+4,382
New +$247K

Similar funds

Bridgefront Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Bridgefront Capital held 829 positions worth $398M, up 17% from $340M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Bridgefront Capital deployed $62.7M of net new capital in Q4 2025, opening 268 new positions and adding to 140 existing holdings. Its largest new stake was e.l.f. Beauty: 59,427 shares worth $4.52M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Lam Research, an estimated $4.81M trimmed.

  • Bridgefront Capital's largest Q4 2025 buy was e.l.f. Beauty: 59,427 shares worth $4.52M.
  • Bridgefront Capital added most to Microsoft in Q4 2025, an estimated $3.81M increase.
  • Bridgefront Capital's biggest Q4 2025 reduction was Lam Research, cutting an estimated $4.81M.
  • Bridgefront Capital fully exited Honeywell in Q4 2025, selling an estimated $3.09M.
  • Bridgefront Capital's ten largest holdings make up 9.7% of its $398M portfolio in Q4 2025.
  • Bridgefront Capital opened 268 new positions and closed 337 in Q4 2025.
  • Bridgefront Capital's portfolio value rose 17% quarter-over-quarter to $398M.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.